BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27319954)

  • 1. Cantharidin in Dermatology.
    Al-Dawsari NA; Masterpol KS
    Skinmed; 2016; 14(2):111-4. PubMed ID: 27319954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Topical Cantharidin Treatment for Molluscum Contagiosum and Warts: A Systematic Review.
    Vakharia PP; Chopra R; Silverberg NB; Silverberg JI
    Am J Clin Dermatol; 2018 Dec; 19(6):791-803. PubMed ID: 30097988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cantharidin Topical Solution 0.7%: First Approval.
    Keam SJ
    Paediatr Drugs; 2024 Jan; 26(1):95-100. PubMed ID: 38007409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cantharidin: a comprehensive review of the clinical literature.
    Torbeck R; Pan M; DeMoll E; Levitt J
    Dermatol Online J; 2014 Jun; 20(6):. PubMed ID: 24945640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cantharidin revisited: a blistering defense of an ancient medicine.
    Moed L; Shwayder TA; Chang MW
    Arch Dermatol; 2001 Oct; 137(10):1357-60. PubMed ID: 11594862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cantharidin therapy for molluscum contagiosum in children.
    Epstein E
    J Am Acad Dermatol; 2001 Oct; 45(4):638. PubMed ID: 11568766
    [No Abstract]   [Full Text] [Related]  

  • 7. [Application of cantharidin, podophyllotoxin, and salicylic acid in recalcitrant plantar warts. A preliminary study].
    López-López D; Agrasar-Cruz C; Bautista-Casasnovas A; Álvarez-Castro CJ
    Gac Med Mex; 2015; 151(1):14-9. PubMed ID: 25739479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molluscum contagiosum: what's new and true?
    Coloe J; Burkhart CN; Morrell DS
    Pediatr Ann; 2009 Jun; 38(6):321-5. PubMed ID: 19588675
    [No Abstract]   [Full Text] [Related]  

  • 9. Childhood molluscum contagiosum: experience with cantharidin therapy in 300 patients.
    Silverberg NB; Sidbury R; Mancini AJ
    J Am Acad Dermatol; 2000 Sep; 43(3):503-7. PubMed ID: 10954663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of recalcitrant plantar warts with long-pulsed Nd:YAG laser versus cantharidin-podophylline resin-salicylic acid.
    Ghonemy S
    J Cosmet Laser Ther; 2017 Oct; 19(6):347-352. PubMed ID: 28489473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cantharidin use among pediatric dermatologists in the treatment of molluscum contagiosum.
    Coloe J; Morrell DS
    Pediatr Dermatol; 2009; 26(4):405-8. PubMed ID: 19689514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cantharidin therapy: practice patterns and attitudes of health care providers.
    Pompei DT; Rezzadeh KS; Viola KV; Lee DH; Schairer DO; Chismar LA; Cohen SR
    J Am Acad Dermatol; 2013 Jun; 68(6):1045-6. PubMed ID: 23680201
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and efficacy of topical cantharidin for the treatment of pediatric molluscum contagiosum: a prospective, randomized, double-blind, placebo-controlled pilot trial.
    Guzman AK; Schairer DO; Garelik JL; Cohen SR
    Int J Dermatol; 2018 Aug; 57(8):1001-1006. PubMed ID: 29904968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cantharidin: a valuable office treatment of molluscum contagiosum.
    Funt TR; Mehr KA
    South Med J; 1979 Aug; 72(8):1019. PubMed ID: 472800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plantar warts: a focus on treatment modalities.
    Lichon V; Khachemoune A
    Dermatol Nurs; 2007 Aug; 19(4):372-5. PubMed ID: 17874607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of cantharidin and podophyllotoxin for the treatment of plantar warts.
    Becerro de Bengoa Vallejo R; Losa Iglesias ME; Gómez-Martín B; Sánchez Gómez R; Sáez Crespo A
    J Am Podiatr Med Assoc; 2008; 98(6):445-50. PubMed ID: 19017852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum.
    Eichenfield LF; Siegfried E; Kwong P; McBride M; Rieger J; Glover D; Willson C; Davidson M; Burnett P; Olivadoti M
    Am J Clin Dermatol; 2021 Mar; 22(2):257-265. PubMed ID: 33599960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How and when to treat molluscum contagiosum and warts in children.
    Smolinski KN; Yan AC
    Pediatr Ann; 2005 Mar; 34(3):211-21. PubMed ID: 15792113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: Molluscum contagiosum. Toxic shock syndrome following cantharidin treatment.
    Langley JM; Soder CM; Schlievert PM; Murray S
    Can Fam Physician; 2003 Jul; 49():887-9. PubMed ID: 12901485
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety of cantharidin: a retrospective review of cantharidin treatment in 405 children with molluscum contagiosum.
    Moye VA; Cathcart S; Morrell DS
    Pediatr Dermatol; 2014; 31(4):450-4. PubMed ID: 24383663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.